Department of Biochemical Pharmacology
Novartis Institutes for Biomedical Research
Dr. Mohammad Hekmatnejad is affiliated to Department of Biochemical Pharmacology, Novartis Institutes for Biomedical Research. Dr. Mohammad Hekmatnejad is currently providing services as Professor. Dr. Mohammad Hekmatnejad has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Mohammad Hekmatnejad contributions have acclaimed recognition from honourable subject experts around the world. Dr. Mohammad Hekmatnejad is actively associated with different societies and academies. Dr. Mohammad Hekmatnejad academic career is decorated with several reputed awards and funding. Dr. Mohammad Hekmatnejad research interests include Department of Biochemical Pharmacology.
MELK is not necessary for the proliferation of basal-like breast cancer cells.